Quotes Dr. Julie Gralow of the Clinical Research Division and director of Breast Cancer Medical Oncology at Seattle Cancer Care Alliance regarding the FDA's accelerated approval of the breast cancer drug Palbociclib earlier this year, among other breast cancer advances
Article about researchers with disabilities includes mention of Dr. Maxine Linial, a virologist at Fred Hutch who lost her sight five years ago after being hit by a car who relies on voice-recognition technology to stay active in her field
Article about the complexities of alcohol and breast cancer risk mentions that Cleavage Creek Winery in California has donated more than $90,000 to fund breast cancer research at Fred Hutch, among other institutions
Slideshow of the first lady of China's U.S. visit last week includes an image of her touring a Fred Hutch HIV vaccine lab with Dr. Gary Gilliland, president and director, and Dr. Julie McElrath, director of the Vaccine and Infectious Disease Division
Article about potential research collaboration between Fred Hutch and Oregon Health & Science University quotes President and Director Dr. Gary Gilliland, who spoke today at the Oregon Bio 2015 conference
Quotes Dr. Larissa Korde, a clinical researcher at Fred Hutch, in an article about how more and more men with breast cancer are opting to get the unaffected breast removed as a precautionary measure against cancer recurrence
Interview with Dr. Fred Appelbaum, deputy director of Fred Hutch and director of Seattle Cancer Care Alliance, about upcoming fundraiser and the promise of cutting-edge cancer therapies such as immunotherapy and proton therapy
Interview with Dr. Martine "Petey" Perrigue about a study she's conducting to determine what is better for optimal health: grazing on small meals throughout the day or eating three square meals without snacking
Article about Fred Hutch spinoff Presage Biosciences, which is pioneering technology that can be used to evaluate up to eight combinations of drugs without exposing patients to the toxicity of systemic dosing.
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Quotes Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research, about the impact of the American Society of Clinical Oncology's "Choosing Wisely" recommendations, which encourage providers and patients to follow evidence-based treatment regimens
Yahoo! News (from U.S. News & World Report), Aug. 19, 2015
Article quotes Dr. Karen Syrjala, co-director of the Fred Hutchinson Cancer Research Center Survivorship Program, with tips on how to overcome memory problems and other issues associated with “chemo brain”
An article highlighting the work of Dr. Grant Trobridge, a former staff scientist at Fred Hutch whose Washington State University lab is developing genetic testing to predict prostate cancer survival and breast cancer recurrence
Profile of Palo Alto-based physician and health care investor Dr. Bob Kocher, whose dream while growing up in Seattle "was to be a leukemia and lymphoma doctor at Fred Hutchinson Cancer Research Center."
Article about a Seattle Sounders fan and Hodgkin disease survivor Kevin Zelko, who is celebrating the end of his cancer treatment by participating in the Climb to Fight Breast Cancer, a fundraiser for Fred Hutch
Article on Science Education Partnership, a Fred Hutch program that provides local teachers with the opportunity to expand their science knowledge and curriculum with hands-on training in Fred Hutch’s and partnering institution’s research labs.
Article about the potential of curing most cancers within the decade quotes Fred Hutch President and Director Dr. Gary Gilliland: "It' is actually plausible that in 10 years we will have cures and therapies for most, if not all cancers."
Article highlighting a partnership between Fred Hutch and New Mexico State University which fosters extensive cancer research activity, develops next generation of cancer scientists and a new level of outreach, primarily to underserved populations across New Mexico
Story about Kirkland resident Jeanette Woldseth, a retired firefighter currently being treated for cancer who is planning to participate in this year's Obliteride by riding 50 miles to raise money for Fred Hutch research
Story on the African-American cancer experience focuses on breast cancer survivor and advocate Bridgette Hempstead of Cierra Sisters, who works as a consultant with Fred Hutch’s Dr. Rachel Ceballos to tailor cancer survivorship programs for minority communities. Ceballos commented that many survivors don’t deal with the emotional aspects of their diagnosis until long after treatment is over.
Article about the research of Fred Hutch's Dr. Maxine Linial, a virologist who studies the enigma of why macaque trainers in Bangladesh are often bitten by their monkeys but rarely become infected by a particular simian retrovirus
Bloomberg Business (from The Seattle Times), June 17, 2015
Article about Seattle's robust biotech industry quotes Robert Nelsen of Arch Venture Partners, who helped launch Juno Therapeutics, an immunotherapy company spun off from research at Fred Hutch, Seattle Children's and Memorial Sloan Kettering Cancer Center
Article about Fred Hutch recruiting its new vice president and chief information officer, Matthew Trunnell, from the Broad Institute also mentions the recent hire of Nicole Robinson, head of licensing and commercialization
Article about a new clinical trial of "Tumor Paint" drug BLZ-100 for pediatric brain cancer patients quotes its inventor, Dr. Jim Olson, a clinical researcher at Fred Hutch and neuro-oncologist at Seattle Children's
Dr. Cameron Turtle, an immunotherapy researcher at Fred Hutch, was interviewed about encouraging new results from treating blood cancer patients with "souped-up" immune cells; he presented the findings recently at the annual meeting of the American Society of Clinical Oncology
Article highlights new technology developed at Fred Hutch in collaboration with Presage Biosciences: a microinjection platform that delivers small doses of up to eight drugs into tumors to assess each drug's ability to kill cancer cells
Article about new class of Howard Hughes Medical Institute Investigators mentions Dr. Sue Biggins, associate head of the Basic Sciences Division at Fred Hutch, is among 26 scientists to receive this prestigious honor
Quotes Dr. Corey Casper, director of Global Oncology at Fred Hutch, and Dr. Jackson Orem, director of the Uganda Cancer Institute; both are co-directors of the new Fred Hutch-UCI Cancer Centre in Kampala, Uganda
Quotes Fred Hutch President and Director Dr. Gary Gillland; Dr. Corey Casper, head of Global Oncology at Fred Hutch and co-director of the UCI/Hutchinson Center Cancer Alliance; and Dr. Jackson Orem, director of the UCI and co-director of the UCI/Hutchinson Center Cancer Alliance
Article about a company called DataStat, which helps researchers automate their workflow, mentions its clients include Fred Hutch, which uses the software to help workers in Zambia organize HIV and AIDS data collection across 21 communities
Quotes Dr. Anne McTiernan about an expert panel she participated on that found a strong association between high alcohol intake and increased risk of liver cancer as well as a protective effect with regard to coffee consumption
Genetic Engineering & Biotechnology News, April 22, 2015
Article covers immunotherapy presentations at the annual meeting of the American Association for Cancer Research, including one by Fred Hutch's Dr. Phil Greenberg, who spoke about his work with genetically engineered T cells that kill cancer
Herald-Tribune (Sarasota, Florida), April 18, 2015
Article about the legacy of baseball great Fred Hutchinson mentions the lifesaving work being done at Fred Hutchinson Cancer Research Center in the U.S. and Uganda and also mentions the Hutch is celebrating its 40th anniversary this year
Fred Hutch's Dr. Jonathan Bricker, who studies the use of technology, such as smartphone apps, to improve health, is among five finalists for GeekWire's annual Geek of the Year Award; cast your vote today!
Dr. Nancy Davidson, former president of the American Society of Clinical Oncology, comments that Ken Burns' PBS cancer documentary "Cancer: The Emperor of All Maladies" could have linked bone-marrow transplant to Fred Hutch, where the procedure was developed to treat leukemia
A conversation with Dr. Anthony Back, a clinical researcher at Fred Hutch who practices at Seattle Cancer Care Alliance and co-directs the Cambia Palliative Care Center of Excellence at the University of Washington
Show explores the breakthroughs Fred Hutch scientists are making, and how Hutch physician-scientists are pioneering new treatments in immunotherapy and cord blood transplantation to fight some of the deadliest forms of cancer
Article about genetic chimerism -- when an individual carries two or more genetically distinct cell lines in different parts of their body -- quotes Fred Hutch's Dr. William Chan, who conducted a study that found male DNA in the brains of autopsied females
Article about proposed legislation by Washington state Sen. Cyrus Habib and Rep. Ross Hunter that would raise the cigarette tax to support cancer research at Fred Hutch, UW and other local research institutions
Article about Fred Hutch awarding grants to three Seattle-area community organizations to help reduce cancer disparities. The article featured grantee Bridgette Hempstead of Cierra Sisters Inc., a breast cancer advocacy organization based in Renton.
Coverage of Seattle Town Hall panel discussion with Fred Hutch's Drs. Fred Appelbaum and Philip Greenberg and "Emperor of All Maladies" cancer documentary director Barak Goodman in advance of its nationwide debut
Article about a University of Washington-led study, involving researchers from Fred Hutch, which found inconsistencies in the accuracy of breast biopsy results across the U.S. for certain types of breast cancer, particularly the noninvasive kind
Profile of Seattle set designer Jennifer Zeyl, who referenced how Intiman theater's collaboration with Fred Hutch on Tony Kushner's "Angels in America" production about HIV/AIDS was an example of good contemporary art that speaks to issues outside the art community
Article about the $2.3 billion sale of Fred Hutch spinout Ikaria to global biopharmaceutical company Mallinckrodt mentions the company was founded by cell biologist Dr. Mark Roth, who also has founded Faraday Pharmaceuticals to develop drugs for treating acute injuries
Article about the link between calorie restriction, endogenous hydrogen sulfide and longevity mentions the research of Dr. Mark Roth, who found that slightly elevated levels of hydrogen sulfide in the air can increase the lifespans of roundworms by 70 percent and can even put mice into a state of suspended animation
Quotes Dr. Gary Gilliland, president and director of Fred Hutch, and Dr. Fred Appelbaum, executive vice president and deputy director, about the contributions of Don and Dottie Thomas to the field of bone marrow transplantation
News roundup mentions that Dr. Sue Biggins of the Basic Sciences Division recently won the Genetics Society of America's Edward Novitski Prize for her work on the kintechore, the molecular machinery that regulates chromosome segregation during cell division
Interview with Dr. Jonathan Bricker about ways to kick the smoking habit in the new year, including participating in his WebQuit.org online study (his segment starts about 16 minutes into the show and runs about 16 minutes)
Roundup of Seahawks fever includes footage of Fred Hutch and Seattle Cancer Care Alliance employees showing their spirit on the Friday before Sunday's big NFC Championship playoff game with the Green Bay Packers